NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid Pharma
Posted by
www.biotecnika.org
A consortium of 24 banks has lent a total of over Rs 3,200 crore to
the drug maker and the lenders will be taking a haircut of around 65%.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nclt-approves-dhanuka-labs-rs-1116-crore-plan-to-buy-debt-hit-orchid-pharma/articleshow/69950982.cms
Subscribe to:
Post Comments (Atom)
Post a Comment